Guard Therapeutics International AB (GUARD)

Market Closed

9 Dec, 15:25

XSTO

1. 38

+0.05

+3.76%

265.57M Market Cap

- P/E Ratio

0% Div Yield

35,800 Volume

-12.7 Eps

kr 1.33

Previous Close

Day Range

1.34 1.4

Year Range

1.1 34.8

Want to track GUARD and more in your Portfolio? 🎯

Get Started For Free

Earnings results expected in 73 days

Summary

GUARD closed today higher at kr1.38, an increase of 3.76% from yesterday's close, completing a monthly increase of 4.55% or kr0.06. Over the past 12 months, GUARD stock lost -92.54%.

GUARD is not paying dividends to its shareholders.

The last earnings report, released on Nov 13, 2025, missed the consensus estimates by -1.29%. On average, the company has fell short of earnings expectations by -1.91%, based on the last three reports. The next scheduled earnings report is due on Feb 20, 2026.

Guard Therapeutics International AB has completed 2 stock splits, with the recent split occurring on Dec 15, 2023.

The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSTO (SEK).

Overview
Earnings
Splits

GUARD Chart

Similar

AIXIA.B

Aixia Group AB

kr -

CLBIO

Corline Biomedical AB

kr 17.2

-1.15%

INDEX

Index Pharmaceuticals Holding AB

kr 0.56

+3.72%

ACOU

Acousort AB

kr 2.47

-6.79%

BIOVIC.B

Biovica International AB

kr -

Guard Therapeutics International AB (GUARD) FAQ

What is the stock price today?

The current price is kr1.38.

On which exchange is it traded?

Guard Therapeutics International AB is listed on XSTO.

What is its stock symbol?

The ticker symbol is GUARD.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 265.57M.

When is the next earnings date?

The next earnings report will release on Feb 20, 2026.

Has Guard Therapeutics International AB ever had a stock split?

Guard Therapeutics International AB had 2 splits and the recent split was on Dec 15, 2023.

Guard Therapeutics International AB Profile

Biotechnology Industry	Healthcare Sector	Mr. Tobias Larsson Agervald CEO	XSTO Exchange	SE0009973357 ISIN
Sweden Country	11 Employees	- Last Dividend	15 Dec 2023 Last Split	- IPO Date

Overview

Guard Therapeutics International AB (publ) is a pioneering pharmaceutical company based in Stockholm, Sweden, focusing on the discovery, development, and commercialization of innovative therapies for the diagnosis and treatment of acute kidney injuries. Originating in 2008 under the name A1M Pharma AB (publ), the company underwent a significant rebranding to become Guard Therapeutics International AB (publ) in October 2019. With a dedicated mission to advance kidney health, Guard Therapeutics aims to transform the landscape of renal care through its groundbreaking research and pharmaceutical solutions.

Products and Services

ROSGard

Guard Therapeutics' flagship product, ROSGard, stands at the forefront of their innovative offerings. This biological drug candidate embodies the company's commitment to preventing kidney damage during acute incidents. ROSGard's therapeutic action is multi-faceted, designed to protect, clean, and repair cells and tissues that become exposed during acute kidney injuries. By targeting these vital processes, ROSGard promises to offer substantial benefits to patients suffering from such dire conditions, highlighting Guard Therapeutics' significant contribution to renal health and medical science.

Contact Information

Address: Nybrogatan 34, 2 tr

Phone: 46 86 70 65 51

Website: https://guardtherapeutics.com

Affiliate Program About Terms Privacy Help Contact Us